Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

Zacks 12:05 ET

S&P and Nasdaq on Track for Third Record Close This Week | Live Stock

Kevin Travers11:17 ET

Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC

Zacks Dec 4 09:35 ET

Incyte Gains Amid Takeover Speculation

Seeking AlphaDec 4 09:11 ET

Merck (MRK.US) / Kelun Biotech's ADC therapy has received breakthrough therapy designation from the FDA for the treatment of non-small cell lung cancer.

Previously, merck (MRK.US) reached a cooperation agreement with CStone Pharmaceuticals (06990), granting merck exclusive rights to develop, produce, and commercialize Sac-TMT outside the greater China region.

Zhitong FinanceDec 4 02:27 ET

Electronic Arts, Lyft and 7 More Stocks That Can Benefit From Trump's R&D Policy

BarronsDec 4 02:00 ET